Aktiverende mutationer i KRAS- genet opstår hyppigt i flere forskellige humane tumorer og har været impliceret i både onkogenese og tumorprogression.
Activating mutations in the KRAS gene occur frequently in a variety human tumours and have been implicated in both oncogenesis and tumour progression.